Baxano Surgical
BAXS
BAXS was delisted on the 21st of November, 2014.
33 hedge funds and large institutions have $4.25M invested in Baxano Surgical in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
14% more funds holding
Funds holding: 29 → 33 (+4)
69% less capital inflows, than outflows
Capital inflows: $412K | Capital outflows: $1.35M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$275K |
| 2 |
HCM
Highlander Capital Management
Short Hills,
New Jersey
|
+$65.3K |
| 3 |
EEG
E.E. Geduld
|
+$18.8K |
| 4 |
UMB Bank
Kansas City,
Missouri
|
+$15.4K |
| 5 |
Guggenheim Capital
Chicago,
Illinois
|
+$13.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$768K |
| 2 |
DAFNA Capital Management
Los Angeles,
California
|
-$340K |
| 3 |
Renaissance Technologies
New York
|
-$162K |
| 4 |
Virtu KCG Holdings
New York
|
-$38.2K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$15.8K |
BAXS Hedge Fund Activity: Q1 2014 in Review
33 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Baxano Surgical (BAXS) for Q1 2014, worth a combined $4.25M — down 14% from $4.94M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BAXS positions and 3 closed out — a net gain of 4 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $275K. The largest seller was Wellington Management Group, exiting entirely with an estimated $768K sold.
- 33 institutional investors held Baxano Surgical (BAXS) as of Q1 2014, up from 29 in Q4 2013.
- Funds reported $4.25M of Baxano Surgical stock for Q1 2014, down 14% quarter-over-quarter.
- 7 funds opened new Baxano Surgical positions in Q1 2014 and 3 closed out, a net change of +4 holders.
- The largest Baxano Surgical buyer in Q1 2014 was Vanguard Group, an estimated $275K added.
- The largest Baxano Surgical seller in Q1 2014 was Wellington Management Group, an estimated $768K sold.
Based on aggregated 13F filings for Q1 2014.